• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

U.S. military to test Bexson Biomedical ketamine delivery device

July 28, 2023 By Sean Whooley

Bexson Biomedical Akeso ketamine delivery device U.S. military
CEO Gregg Peterson presents AKESO device to military innovation leaders. [Image courtesy of Bexson Biomedical]
Bexson Biomedical announced that the U.S. military intends to field-test its Akeso wearable ketamine delivery device.

Akeso, a ruggedized version of Bexson Biomedical’s wearable infusion device, utilizes Sevalent technology. Sevalent, Bexson’s proprietary formulation platform can work with small molecules across a broad range of drug classes. It enables subcutaneous intravenous (IV) therapy delivery.

Bexson management believes Akeso can provide rapid ketamine-based pain relief to soldiers in contested environments. The lightweight, durable device can provide simplicity of use by both medical and non-medical personnel. According to the company, it could enhance the efficiency of administration, better serving the U.S. military.

The training comes as part of Northern Strike, a military training and readiness exercise, taking place next month. Northern Strike includes 10,000 service members across all five U.S. military branches. It tests the readiness of forces working in concert with invited NATO partners.

Bexson said in a news release that the military utilizes ketamine for pain management in austere and contested environments. Guidelines call for it to treat pain, primarily by IV administration.

The company says military personnel will receive training to use the device on the battlefield as a potential future alternative to IV administration. Bexson intends to have engineers on hand to gain input on device utility and learn about its use, impact and outcomes.

“While IV is an effective route of administration for drug delivery, there are major limitations and inefficiencies when used on the battlefield, and thus, we believe there is an urgent identifiable need for a medicine delivery platform that is faster and simpler for use in contested environments,” said Gregg Peterson, co-founder & CEO, Bexson Biomedical. “We believe this device will be a game changer for the military, and we’re honored to be involved in this training exercise.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pain Management Tagged With: Bexson Biomedical

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS